Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis.
Yu XiongXiumei GuoXinyue HuangXiaodong KangJianfeng ZhouChunhui ChenZhigang PanLinxing WangRoland GoldbrunnerLampis StavrinouPantelis StavrinouShu LinYuping ChenWeipeng HuFeng ZhengPublished in: PloS one (2023)
Tranexamic acid can significantly reduce the risk of intracranial haemorrhage growth in patients with ICH and TBI. Tranexamic acid can reduce the incidence of complications (hydrocephalus, rebleeding) in patients with SAH, which can indirectly improve the quality of life of patients with intracranial haemorrhage.